Abstract:Both particulate matter with aerodynamics of less than 2.5 (PM2.5) and ozone are the two main air pollutants in China, which seriously endanger human health. To estimate the adverse impacts of PM2.5 and ozone on human health during the implementation of air pollution prevention and control actions in Chengdu, both the generalized additive model and the nonlinear distribution lag model of epidemiology were adopted to explore the exposure-response relationship coefficients β of daily ozone 8h maximum concentration average (O3-8h), as well as that of PM2.5 on disease deaths in Chengdu from 2014 to 2016. On this basis, the environmental risk model and environmental value assessment model were both adopted to evaluate the health effects and health benefits in Chengdu from 2016 to 2020, respectively, with the assumption that PM2.5 and O3-8h concentration were reduced to specified air pollution control limits (35 μg·m-3 and 70 μg·m-3, respectively). The results showed 1 the annual concentration of PM2.5 presented gradually decreasing trends in Chengdu from 2016 to 2020. Specifically, ρ(PM2.5) from 63 μg·m-3 in 2016 decreased to 40.92 μg·m-3 in 2020. The average annual decline rate was approximately 9.8%. In contrast, the annual concentration of O3-8h from 155 μg·m-3 in 2016 increased to 169 μg·m-3 in 2020, and the increasing rate was approximately 2.4%. 2 Both PM2.5 and O3-8h had lag effects on three types of disease deaths. Under the maximum lag effect, the corresponding exposure-response relationship coefficients β of PM2.5were 0.0003600, 0.0005001, and 0.0009237 for all-cause, cardiovascular, and respiratory premature deaths, respectively, whereas the corresponding β of O3-8h were 0.0003103, 0.0006726, and 0.0007002, respectively. 3 If ρ(PM2.5) was reduced to the national secondary standard limit (35 μg·m-3), the corresponding number of health beneficiaries and economic benefits declined yearly. Specifically, the health beneficiary number of all-cause, cardiovascular, and respiratory disease deaths were reduced from 1128, 416, and 328 in 2016 to 229, 96, and 54 in 2020, respectively. There were a total number of 3314 avoidable premature deaths for all-cause diseases during the five years, resulting in a total health economic benefit of 7.66 billion yuan. 4 If we assume that ρ(O3-8h) was reduced to the concentration limit specified by the World Health Organization (70 μg·m-3), the corresponding number of health beneficiaries and economic benefits were increasing yearly. Specifically, the health beneficiaries' numbers of all-cause, cardiovascular, and respiratory disease deaths rose from 1919, 779, and 606 in 2016 to 2429, 1157, and 635 in 2020, respectively. The annual average growth rates of avoidable all-cause and cardiovascular mortality were 6.85% and 10.72%, respectively, which was higher than the annual average rise rate of ρ(O3-8h). There were 10790 total avoidable deaths from all-cause diseases during the five years, resulting in a total health economic benefit of 26.62 billion yuan. These findings indicate that PM2.5 pollution in Chengdu had been well controlled, whereas O3 pollution had become more severe and had become another key air pollutant threatening human health. Therefore, the synchronous control of PM2.5 and ozone should be implemented in the future.

Analyses of air pollution control measures and co-benefits in the heavily air-polluted Jinan city of China, 2013–2017

Cost-benefit Analysis of China’s Action Plan for Air Pollution Prevention and Control

An Assessment of the Potential Health Benefits of Realizing the Goals for PM 10 in the Updated Chinese Ambient Air Quality Standard

Drivers of Improved PM2.5 Air Quality in China from 2013 to 2017.

Air quality improvements and health benefits from China’s clean air action since 2013

[Health Impact Attributable to the Control of PM2.5 Pollution in China During 2013-2017].

An Economic Evaluation of the Health Effects of Reducing Fine Particulate Pollution in Chinese Cities

Rapid improvement of PM 2.5 pollution and associated health benefits in China during 2013–2017

Substantial Reductions in Ambient PAHs Pollution and Lives Saved As a Co-Benefit of Effective Long-Term PM2.5 Pollution Controls

Health Benefit of Air Quality Improvement in Guangzhou, China: Results from a Long Time-Series Analysis (2006–2016)

Air Quality and Health Benefits of China’s Current and Upcoming Clean Air Policies

Air pollution control and carbon reduction policies: Assessing effectiveness in alleviating PM 2.5 -associated mortality in China

[Health Benefit Evaluation for PM2.5 as Well as O3-8h Pollution Control in Chengdu, China from 2016 to 2020]

Co-benefits of carbon and pollution control policies on air quality and health till 2030 in China

Health benefits of on-road transportation pollution control programs in China.

Health Benefits of Improving Air Quality in Taiyuan, China.

[Health Benefit Analyses of the Clean Air Action Plan Implementation in Shanghai].

Improving Air Pollution Control Policy in China-A Perspective Based on Cost-Benefit Analysis

Health Benefits from Improved Air Quality: Evidence from Pollution Regulations in China's " " Cities

How the Air Clean Plan and Carbon Mitigation Measures Co-Benefited China in PM2.5 Reduction and Health from 2014 to 2020

PM2.5-Related Health Economic Benefits Evaluation Based on Air Improvement Action Plan in Wuhan City, Middle China